A group of organic compounds, including the benzopyran series, includes powerful vasorelaxant drugs, such as cromakalim, an example of a potassium channel opener used in the treatment of cardiovascular diseases [28]. This evidence concerns the gene KCNA3 and cardiovascular disorder.